BioStem Technologies Invites You to Quarterly Results Call
Exciting Announcement from BioStem Technologies
BioStem Technologies Inc. (BSEM), a prominent MedTech firm renowned for its innovation in advanced wound care, is gearing up for a significant event. The company has announced that it will unveil its financial results for the second quarter of 2025 on a thrilling conference call scheduled for August 14, 2025, at 4:30 PM ET. This session will undoubtedly provide valuable insights into BioStem's performance and future direction.
Conference Call Details
The upcoming conference call will be led by CEO Jason Matuszewski and CFO Michael Fortunato, who will guide attendees through the financial results and provide updates regarding the Company’s Form 10 filing and anticipated Nasdaq uplisting. For those wishing to register for the event, the process is straightforward and accessible, promoting participation from all interested parties.
How to Join the Conference Call
To ensure you don’t miss out on the financial insights from BioStem Technologies, make note of the following information:
- Conference ID: 9695874
- North America Toll-Free: (800) 715-9871
- International Toll: +1 (646) 307-1963
Webcast Information
Participants can join via a live webcast. The link will be available on BioStem's official communication channels, making it easy for everyone to access this informative session.
Staying Connected with BioStem Technologies
BioStem Technologies encourages everyone to join its distribution list and follow its social media channels. This initiative will keep you updated on the latest developments and innovations coming from the company. You can sign up for their email distribution list for the latest news and updates about their breakthroughs in medical technologies.
Why Follow BioStem Technologies?
BioStem Technologies stands at the forefront of utilizing perinatal tissue effectively, focusing on developing products that significantly enhance wound care treatment. By adopting its proprietary BioREtain processing method, BioStem ensures that essential growth factors are preserved, providing patients with the most effective care options.
Quality Assurance
BioStem's commitment to safety and effectiveness is underscored by its various accreditations. The company’s products are manufactured in accordance with Good Tissue Practices (cGTP) and Good Manufacturing Processes (cGMP) and they hold certifications from the American Association of Tissue Banks (AATB), reinforcing their dedication to quality.
About BioStem Technologies
Incorporating an innovative approach, BioStem Technologies, Inc. (BSEM) specializes in the field of regenerative medicine, directing its efforts towards the commercialization of allografts vital for advancing wound care. The Company’s portfolio boasts exceptional brands such as AmnioWrap2™, VENDAJE®, and American Amnion™, each providing unique solutions for healthcare professionals.
Contact Information
If you have any inquiries or need assistance regarding the upcoming conference call or BioStem's range of products, feel free to reach out to:
BioStem Technologies, Inc.
Adam Holdsworth
Director of Investor Relations
Email: adam@biostemtech.com
Phone: 917-497-9287
Frequently Asked Questions
When is BioStem's financial results conference call scheduled?
BioStem Technologies will host its conference call on August 14, 2025, at 4:30 PM ET.
Who will lead the conference call?
CEO Jason Matuszewski and CFO Michael Fortunato will lead the call.
How can I register for the conference call?
Details for registration can be found on BioStem's official platforms.
What is the primary focus of BioStem Technologies?
BioStem Technologies focuses on the development, manufacture, and commercialization of placental-derived products for advanced wound care.
How does BioStem ensure quality in its products?
Their products are manufactured under strict guidelines, adhering to cGTP and cGMP, and are accredited by the AATB.
About The Author
Contact Caleb Price privately here. Or send an email with ATTN: Caleb Price as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.